These T lymphocytes were predominantly CD8+ cytotoxic lymphocytes, whereas CD4+ T lymphocytes were scarce in the adenocarcinoma and lymph node metastases and were mainly absent in the bulky tumor. The gene discussed is CD8A; the disease is neoplasm.